- Home
- VSTM vs FFA Comparison
VSTM vs FFA Comparison
Compare VSTM & FFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VSTM | FFA |
|---|---|---|
| Founded | 2010 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.7M | 428.9M |
| IPO Year | 2011 | 2004 |
Fundamental Metrics
Financial Performance| Metric | VSTM | FFA |
|---|---|---|
| Price | $5.62 | $21.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $16.50 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 36.1K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.49 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,914,000.00 | N/A |
| Revenue This Year | $282.64 | N/A |
| Revenue Next Year | $72.25 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 209.14 | N/A |
| 52 Week Low | $4.01 | $17.46 |
| 52 Week High | $11.25 | $22.31 |
Technical Indicators
Market Signals| Indicator | VSTM | FFA |
|---|---|---|
| Relative Strength Index (RSI) | 52.94 | 53.56 |
| Support Level | $5.48 | $21.02 |
| Resistance Level | $6.79 | $21.78 |
| Average True Range (ATR) | 0.40 | 0.33 |
| MACD | 0.07 | 0.14 |
| Stochastic Oscillator | 89.67 | 90.12 |
Price Performance
Historical ComparisonAbout VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About FFA First Trust Enhanced Equity Income Fund
First Trust Enhanced Equity Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide high level of current income and gains and, to a lesser extent, capital appreciation. The Fund pursues its investment objective by investing in a diversified portfolio of equity securities.